Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19
Author:
Affiliation:
1. Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Publisher
Mary Ann Liebert Inc
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Link
https://www.liebertpub.com/doi/pdf/10.1089/apc.2020.0118
Reference9 articles.
1. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients
2. Repurposing FDA-Approved Drugs for COVID-19 Using a Data-Driven Approach
3. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Building a Cohort of Transgender and Nonbinary Patients from the Electronic Medical Record;LGBT Health;2023-12-28
2. Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials;Annals of Epidemiology;2023-09
3. SARS-CoV-2 Infection and Testing Experiences in a Nationwide Sample of Transgender and Gender-Diverse Adults, June–December 2021;Public Health Reports;2022-12-22
4. Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review;World Journal of Methodology;2022-11-20
5. TransCOVID: Does Gender-Affirming Hormone Therapy Play a Role in Contracting COVID-19?;Journal of Sex & Marital Therapy;2021-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3